Thanks to its strong international
distribution network, Laboratoires VIVACY is present on the medical aesthetics market in over 70 countries. Its main goal is to design and deliver innovative anti-ageing solutions in collaboration with physicians and biotechnology professionals worldwide. Driven by its growing success,
VIVACY has made a big investment in a new high-tech manufacturing facility. Located in the beautiful and dynamic Haute-Savoie region (France), this new 3500 m2
factory
can be described as a centre of advanced manufacturing technologies, innovation, research and product development, built in compliance with European and international standards. VIVACY is hoping to extend its
international boarders by distributing STYLAGE® into the Chinese market by 2014, and is currently looking for partners to establish strong distribution channels in the US.
An innovative anti-ageing solution Facial proportions play a significant role in how beauty is perceived. A youthful face is one that is full and smoothly contoured. As we age, our face naturally loses volume, which can happen as early as our mid-20s or 30s, and especially in those who diet or excessively exercise. Even if lines or wrinkles are not
apparent, the loss of underlying soft tissue can cause drooping or sagging skin, depressed or hollowed cheeks, which eventually give the face a wan, tired appearance. Therefore, restoring facial volume is an effective and immediate way in which to improve facial proportions and create a natural, youthful look.
Launched in 2012, STYLAGE® XXL is not only a wrinkle filler, but also a volumiser. It is a monophasic cross-linked HA with added mannitol, specifically designed to restore that fullness of youth and provide underlying facial structure in the three most important areas of the face: the cheekbones, facial oval and chin. It is available in packages of one sterile pre-filled syringe of 2.2 ml or two syringes of 1 ml.
Stress-free patients, efficient doctors The whole range of STYLAGE® (S, M, Special Lips, L, XL) is now available with a Lidocaine. STYLAGE® is the first product on the market which contains cross-linked HA (patented IPN-Like Technology), antioxidant (Mannitol), and Lidocaine for comfort and safety — for both for patients and physicians. A clinical study conducted by
French plastic surgeon, Dr Bernard Mole confirms that the effectiveness of the HA is not compromised by the addition of Lidocaine, and that the performance and filling capacity of gels with STYLAGE® Lidocaine are the same as those without. The study, which was carried out on 84 patients with a clinical follow-up of 6–8 months, concluded that the product does not bring about any increased risk of blood extravasation and affects neither the quality or durability of the results. Although the few seconds it takes
to initially insert the product may be uncomfortable, the rest of the injection is far more tolerable. The correction can therefore be refined under much better conditions. This increased comfort throughout the injection process confirms the notion that the addition of lidocaine is a key step forward in putting the
STYLAGE® treatment performed by Dr Marcin Ambroziak, (A) before and (B) after treatment. Products used: STYLAGE® Special Lips for lip enhancement, STYLAGE® M for perioral lines and wrinkles around the mouth.
patient at ease. So, for comfort and durability with minimal downtime, STYLAGE® is the obvious choice for patients and physicians.
Further information
www.vivacy.fr AMWC Booth number L3
Images ç Vivacy/Stylage Reference
1. Mole B, Gozlan L. Benefits of adding lidocaine to a hyaluronic gel – STYLAGE® M. J Cosmet Laser Ther 201; 13(5): 249–54
prime-journal.com | March 2013 ❚ 117
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128 |
Page 129 |
Page 130 |
Page 131 |
Page 132 |
Page 133 |
Page 134 |
Page 135 |
Page 136 |
Page 137 |
Page 138 |
Page 139 |
Page 140